A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain.
about
Tapentadol hydrochloride: A novel analgesicRole of Tapentadol Immediate Release (Nucynta) in the Management Of Moderate-to-Severe PainSystematic literature review and meta-analysis of the efficacy and safety of prescription opioids, including abuse-deterrent formulations, in non-cancer pain managementThe use of opioids in fibromyalgiaReady conversion of patients with well-controlled, moderate to severe, chronic malignant tumor-related pain on other opioids to tapentadol extended releasePost hoc analyses of data from a 90-day clinical trial evaluating the tolerability and efficacy of tapentadol immediate release and oxycodone immediate release for the relief of moderate to severe pain in elderly and nonelderly patientsTapentadol immediate release: a new treatment option for acute pain managementTapentadol in pain management: a μ-opioid receptor agonist and noradrenaline reuptake inhibitor.[Undesired side effects of tapentadol in comparison to oxycodone. A meta-analysis of randomized controlled comparative studies].Anesthetic Routines: The Anesthesiologist's Role in GI Recovery and Postoperative IleusTapentadol for Cancer Pain Management: A Narrative Review.Patient considerations in the use of tapentadol for moderate to severe pain.Health Care Utilization and Costs Associated with Nausea and Vomiting in Patients Receiving Oral Immediate-Release Opioids for Outpatient Acute Pain Management.Tapentadol immediate release for the relief of moderate-to-severe acute pain.Tapentadol immediate-release for acute pain.Current considerations for the treatment of severe chronic pain: the potential for tapentadol.Tapentadol for pain: a treatment evaluation.New health care measures: emphasis on better management of postsurgical pain and postoperative nausea and vomiting.Acute pain service: past, present and future.Improving acute pain management in emergency medicine.Exploring the Interplay between Rescue Drugs, Data Imputation, and Study Outcomes: Conceptual Review and Qualitative Analysis of an Acute Pain Data Set.Efficacy and Safety of Tapentadol Immediate Release Assessment in Treatment of Moderate to Severe Pain: A Systematic Review and Meta-Analysis.Economic and clinical burden of opioid-induced nausea and vomiting.Unique pharmacology of tapentadol for treating acute and chronic pain.Tapentadol, oxycodone or placebo for acute pain of vertebral compression fractures: a randomized Phase IIIb study.Indomethacin submicron particle capsules provide effective pain relief in patients with acute pain: a phase 3 study.Lower-dose diclofenac submicron particle capsules provide early and sustained acute patient pain relief in a phase 3 study.A randomised, placebo-controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans.A phase 3, randomized, placebo-controlled trial of DepoFoam® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy.Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study.Pharmacokinetic and pharmacodynamic modeling of opioid-induced gastrointestinal side effects in patients receiving tapentadol IR and oxycodone IR.Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting Analgesic.Tapentadol--the evidence so far.Serotonin Syndrome in Tapentadol Literature: Systematic Review of Original Research.
P2860
Q24629365-A3083F5F-9E91-448B-B359-CB28185B4335Q24632728-9DCFEFF6-E2C7-4462-A673-BBD06507D12AQ26853312-9579CAE3-D17B-4CAD-878E-BA79C1738431Q28305020-F1942767-6E41-4D60-8D34-ED088978EB98Q33775071-1939E8C8-340B-4ED2-BE10-4D0B17966BD2Q34068571-D15BF85C-6709-4860-BB07-D83488B46A42Q34418280-AE4915B9-BC4A-4A58-A8A5-6362D73D819AQ34628322-47EC9460-3A03-4E17-9C73-8B48A3CBAADCQ34636179-8E6C948D-E8BF-4B82-9F24-90335E28E057Q35202119-D635A2C1-A831-4353-B487-E50710D44180Q36248445-BB1CFC6B-1809-4388-986D-8988B9AB1BFFQ36991981-231886E4-6370-4CD1-90AE-9856A522EDC5Q37459026-BD7CD091-09C4-49E6-BE1E-4965DF093D82Q37606489-E44C0A3C-47BE-46A4-98F5-77C70BD43896Q37762253-BF2AC10B-A6B0-4BF3-9726-CCF66163BAADQ37907389-34488A1A-D6AC-4383-8A01-FFA98CC93EACQ37970786-C82C6EE0-E44B-4635-AF2A-54C778F44B6BQ38190848-C126F041-B168-4E7F-90BB-44FA095C595AQ38299530-B39ABC3E-614E-432D-8266-A22C378423C9Q38317178-5D48A96C-1F85-40F2-89D4-224C55C0430DQ38662786-5B430D03-807B-47DF-80AF-D0A7EDCB6DA0Q38925543-974649C2-1976-4F67-A389-CEB413396C53Q38969079-365DE26A-383D-4833-AC2E-CE1AC0FF7F35Q38980690-C23DD512-DF68-4640-A7A5-7E1C00C2E80EQ39209916-7B39C3C0-9C1E-4C0F-939A-78E517DB85F4Q39217247-AFE9DA9D-10A9-41C8-86BE-FC45A6B72ED2Q39219199-326D9812-EC94-46E3-ABDB-16BB8856E3ABQ39251525-CCF1304C-2933-47BF-B95D-50DA18CD98AAQ39260909-0DA21368-7B1D-4524-B30C-BBEF7456391EQ43005382-C7576316-D3F4-44A2-9C58-A9956E75A42CQ44334357-4337CA0A-82D3-47E5-9B79-4D246FB6EBC2Q47261672-EB3D927A-2FDE-4AC0-812B-CC9E5A528844Q47722427-50ACBF8F-5A26-4D45-9833-71235F5DCC9DQ50035203-99F615AC-2D01-44BB-9C58-78DE81645CD1
P2860
A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
A randomized, double-blind, pl ...... d oxycodone IR for acute pain.
@en
A randomized, double-blind, pl ...... d oxycodone IR for acute pain.
@nl
type
label
A randomized, double-blind, pl ...... d oxycodone IR for acute pain.
@en
A randomized, double-blind, pl ...... d oxycodone IR for acute pain.
@nl
prefLabel
A randomized, double-blind, pl ...... d oxycodone IR for acute pain.
@en
A randomized, double-blind, pl ...... d oxycodone IR for acute pain.
@nl
P2093
P1476
A randomized, double-blind, pl ...... d oxycodone IR for acute pain.
@en
P2093
Akiko Okamoto
Charles Oh
David Upmalis
Jens-Ulrich Stegmann
Stephen Daniels
P304
P356
10.1185/03007990902952825
P407
P577
2009-06-01T00:00:00Z